← Back to Clinical Trials
Recruiting NCT05935124

NCT05935124 White Light vs Narrow Band Imagingin the Diagnosis of Right Sided Colonic Polyps in Asymptomatic Subjects Undergoing Screening Colonoscopy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05935124
Status Recruiting
Phase
Sponsor Western Sydney Local Health District
Condition Adenoma Colon
Study Type INTERVENTIONAL
Enrollment 600 participants
Start Date 2015-08-01
Primary Completion 2025-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
WLE first, then B-NBI

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 600 participants in total. It began in 2015-08-01 with a primary completion date of 2025-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A randomized controlled crossover study to determine if narrow band imaging or white light endoscopy is superior in detecting right colonic polyps in average risk subjects undergoing screening colonoscopy

Eligibility Criteria

Inclusion Criteria: * Asymptomatic subjects undergoing screening colonoscopy * age \> 50. * average risk subjects defined as those without a personal history of inflammatory bowel disease, colon adenoma or cancer or family history of FAP or Familial non-polyposis syndrome or first degree relatives having diagnosed to have colo-rectal carcinoma, no colonoscopy in past 5 years and, ability to provide a written consent to trial participation Exclusion Criteria: * unable to consent

Contact & Investigator

Central Contact

Michael Bourke, MBBS

📞 8890555

Frequently Asked Questions

Who can join the NCT05935124 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Adenoma Colon. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05935124 currently recruiting?

Yes, NCT05935124 is actively recruiting participants. Visit ClinicalTrials.gov or contact Western Sydney Local Health District to inquire about joining.

Where is the NCT05935124 trial being conducted?

This trial is being conducted at Sydney, Australia.

Who is sponsoring the NCT05935124 clinical trial?

NCT05935124 is sponsored by Western Sydney Local Health District. The trial plans to enroll 600 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology